MedTech & Diagnostics
DarioHealth Executive Compensation (FY24)
DRIO · Executive and director compensation, fiscal 2022 to 2024
Chief executive, fiscal 2024 ◇ Erez Raphael | Latest say-on-pay support = January 29, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
The DarioHealth brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of October 22, 2026Latest filing (8-K): January 29, 2026
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Member, one year
136 figures on this page: 132 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Erez Raphael: $722,187 → $1,962,084 (171.7% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is DarioHealth's chief executive and what were they paid?
Erez Raphael, Chief Executive Officer, received $1,962,084 in total compensation for fiscal 2024. Raphael's total moved 171.7% higher from the $722,187 reported for fiscal 2023.
What was DarioHealth's say-on-pay result?
Shareholders supported the say-on-pay proposal with 97.4% of votes cast for or against in favor at the meeting held January 29, 2026 for fiscal 2025.
What is DarioHealth's chief executive pay ratio?
The company reported a chief executive pay ratio of 2:1 for fiscal 2024.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Erez Raphael Chief Executive Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Richard Anderson President | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Zvi Ben David Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Dror Bacher Chief Operating Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Erez Raphael Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Richard Anderson Former President | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
Zvi Ben David former Chief Financial Officer | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Tomer Ben Kiki Former Chief Operations Officer Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Erez Raphael Chief Executive Officer | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Richard Anderson Former President Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Zvi Ben David former Chief Financial Officer Departed during or after this year | ◇ | — | ◇ | — | — | — | ◇ | ◇ |
Steven Nelson Chief Commercial Officer | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Erez Raphael | RSA | ◇ | — | — | ◇ | — | — | ◇ |
| Richard Anderson | OPTION | ◇ | — | — | ◇ | — | ◇ | — |
| Steven Nelson | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Tomer Ben-Kiki | OPTION | ◇ | — | — | ◇ | — | ◇ | — |
| Tomer Ben-Kiki | OPTION | ◇ | — | — | ◇ | — | ◇ | — |
| Zvi Ben David | RSA | ◇ | — | — | ◇ | — | — | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Richard Anderson | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Erez Raphael
Chief Executive Officer · Employment agreement
| Equity acceleration on change in control | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Non-compete period | ◇ |
Steven Nelson
Chief Commercial Officer · Offer letter
| Severance cash amount | ◇ |
| Change-in-control trigger | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
Zvi Ben David
former Chief Financial Officer · Employment agreement
| Severance base | ◇ |
| Change-in-control trigger | ◇ |
| Equity acceleration on change in control | ◇ |
| Excise tax treatment | ◇ |
| Non-compete period | ◇ |
| Non-solicit period | ◇ |
| Clawback | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2024
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Dennis M. McGrath | ◇ | ◇ | — | — | — | — | ◇ |
Yoav Shaked | ◇ | ◇ | — | — | — | — | ◇ |
Dennis Matheis | ◇ | ◇ | — | — | — | — | ◇ |
Hila Karah | ◇ | ◇ | — | — | — | — | ◇ |
Adam Stern | ◇ | ◇ | — | — | — | — | ◇ |
Jon Kaplan | ◇ | ◇ | — | — | — | — | ◇ |
Erez Raphael and Lawrence Leisure served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Total board retainer | ◇ |
| Audit committee member | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance member | ◇ |
Equity is delivered as Restricted Shares.
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | January 29, 2026 | = | ◇ | ◇ | ◇ |
| 2022 | December 11, 2023 | = | ◇ | ◇ | ◇ |
| 2019 | October 14, 2020 | = | ◇ | ◇ | ◇ |
| 2016 | December 4, 2017 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Chief executive total compensation
◇
Velarion Pro: every company page, peer tools and exports, one seat
One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Erez Raphael (Chief Executive Officer), FY2024 total compensation $1,962,084 (base salary $448,293) [exec_comp, SEC accession 0001104659-25-123724, filed 2025-12-22]What this page does not include
Everything above is a fact DarioHealth disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
136 figures on this page: 132 cited to the filing that reported them, 4 calculated from figures it prints.
132 cited to the filing
4 calculated from the filing
Documents cited
- 0001104659-26-007974Item 5.07 Submission of Matters to a Vote of Security Holders.
- 0001104659-25-123724ELECTION OF EACH OF THE DIRECTOR NOMINEES. &
- 0001104659-24-068526Exhibit
- 0001104659-23-124996Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001104659-23-111764
- 0001104659-20-114883Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001144204-17-062395Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001144204-17-038322Exhibit
- 0001144204-15-001590Exhibit
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “DarioHealth executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/DRIO (accessed 2026).
Short form: data: Velarion
The DarioHealth brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about DarioHealth and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}